Assessing the Minimally Clinically Significant Difference: Scientific Considerations, Challenges and Solutions

10.1056/NEJM198712103172409

American Society of Clinical Oncology, 1996, J Clin Oncol, 14, 671, 10.1200/JCO.1996.14.2.671

10.1177/009286150203600127

Sloan J, 2003, J Drug Inform Journal, 37, 23, 10.1177/009286150303700105

Patrick D L, 2000, Med Care, 38, II14

10.1001/jama.1997.03550010061041

Cella D F, 1996, Oncology, 10, 233

Frost M H, 2002, Am J Manage Care, 8, S574

Samsa G, 1999, Pharmacoeconomics, 2, 142

10.1081/BIP-120028508

10.1016/S0895-4356(96)00206-5

10.4065/77.4.371

10.1016/0197-2456(89)90005-6

10.1016/0895-4356(94)90036-1

10.1136/bmj.316.7132.690

10.4065/77.4.367

10.1586/14737167.4.5.515

Sloan J A, 2003, J Cancer Integr Med, 1, 41

Norman G R, 2003, Med Care, 41, 582

10.1093/jnci/92.3.205

10.1002/1097-0142(197607)38:1<388::AID-CNCR2820380156>3.0.CO;2-A